Homodimerization of Neuropeptide Y Receptors Investigated by Fluorescence Resonance Energy Transfer in Living Cells*

Up to now neuropeptide Y (NPY) receptors, which belong to the large family of G-protein-coupled receptors and are involved in a broad range of physiological processes, are believed to act as monomers. Studies with the Y1-receptor antagonist and Y4-receptor agonist GR231118, which binds with a 250-fold higher affinity than its monomer, led to the first speculation that NPY receptors can form homodimers. In the present work we used the fluorescence resonance energy transfer (FRET) to study homodimerization of the hY1-, hY2-, and hY5-receptors in living cells. For this purpose, we generated fusion proteins of NPY receptors and green fluorescent protein or spectral variants of green fluorescent protein (cyan, yellow, and red fluorescent protein), which can be used as FRET pairs. Two different FRET techniques, fluorescence microscopy and fluorescence spectroscopy, were applied. Both techniques clearly showed that the hY1-, hY2-, and hY5-NPY receptor subtypes are able to form homodimers. By using transiently transfected cells, as well as a stable cell line expressing the hY2-GFP fusion protein, we could demonstrate that the Y-GFP fusion proteins are still functional and that dimerization varies from 26 to 44% dependent on the receptor. However, homodimerization is influenced neither by NPY nor by Gα protein binding.

[1]  S. Hirose,et al.  Ig-Hepta, a Novel Member of the G Protein-coupled Hepta-helical Receptor (GPCR) Family That Has Immunoglobulin-like Repeats in a Long N-terminal Extracellular Domain and Defines a New Subfamily of GPCRs* , 1999, The Journal of Biological Chemistry.

[2]  E I Canela,et al.  Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Cornea,et al.  Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.

[5]  Lakshmi A. Devi,et al.  Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.

[6]  R. Tsien,et al.  Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein. , 2000, Methods in enzymology.

[7]  S. Schulz,et al.  Homo- and Heterodimerization of Somatostatin Receptor Subtypes , 2001, The Journal of Biological Chemistry.

[8]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.

[9]  L. Calzà,et al.  Daily changes of neuropeptide Y-like immunoreactivity in the suprachiasmatic nucleus of the rat , 1990, Regulatory Peptides.

[10]  J. Galzi,et al.  Rapid Internalization and Recycling of the Human Neuropeptide Y Y1 Receptor* , 2002, The Journal of Biological Chemistry.

[11]  R. Tsien,et al.  Fluorescence resonance energy transfer analysis of cell surface receptor interactions and signaling using spectral variants of the green fluorescent protein. , 2001, Cytometry.

[12]  J. Leban,et al.  High-affinity neuropeptide Y receptor antagonists. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Ciruela,et al.  Characterization of the Dimerization of Metabotropic Glutamate Receptors Using an N‐Terminal Truncation of mGluR1α , 1999, Journal of neurochemistry.

[14]  A. Blomqvist,et al.  Y-receptor subtypes—how many more? , 1997, Trends in Neurosciences.

[15]  A. Sorkin,et al.  Interaction of EGF receptor and Grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy , 2000, Current Biology.

[16]  J. Wess,et al.  Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. , 1998, Biochemistry.

[17]  J. Morrison,et al.  Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells* , 1997, The Journal of Biological Chemistry.

[18]  Fred S. Wouters,et al.  Imaging FRET between spectrally similar GFP molecules in single cells , 2001, Nature Biotechnology.

[19]  L. Gama,et al.  Dimerization of the Calcium-sensing Receptor Occurs within the Extracellular Domain and Is Eliminated by Cys → Ser Mutations at Cys101 and Cys236 * , 1999, The Journal of Biological Chemistry.

[20]  Xuejun Jiang,et al.  Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells. , 2002, Molecular biology of the cell.

[21]  Paul R. Selvin,et al.  The renaissance of fluorescence resonance energy transfer , 2000, Nature Structural Biology.

[22]  G. Demontis,et al.  G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.

[23]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Milligan,et al.  Molecular manipulation of G-protein-coupled receptors: a new avenue into drug discovery. , 2000, Current medicinal chemistry.

[25]  A. Inui,et al.  Neuropeptide Y feeding receptors: are multiple subtypes involved? , 1999, Trends in pharmacological sciences.

[26]  R. Heim,et al.  Using GFP in FRET-based applications. , 1999, Trends in cell biology.

[27]  B. Herman,et al.  Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. , 1998, Biophysical journal.

[28]  R. Mitra,et al.  Fluorescence resonance energy transfer between blue-emitting and red-shifted excitation derivatives of the green fluorescent protein. , 1996, Gene.

[29]  A. Beck‐Sickinger,et al.  Molecular characterization of the ligand–receptor interaction of the neuropeptide Y family , 2000, Journal of peptide science : an official publication of the European Peptide Society.

[30]  P. Seeman,et al.  Dopamine D2 receptor dimers and receptor-blocking peptides. , 1996, Biochemical and biophysical research communications.

[31]  G. Patterson,et al.  Förster distances between green fluorescent protein pairs. , 2000, Analytical biochemistry.

[32]  K. Blumer,et al.  G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.

[33]  L. Limbird,et al.  Localization of G-protein-coupled receptors in health and disease. , 2000, Trends in pharmacological sciences.

[34]  H Herzog,et al.  XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. , 1998, Pharmacological reviews.

[35]  H. Land,et al.  A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. , 1990, Nucleic acids research.

[36]  E. Brown,et al.  Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 Cells* , 1998, The Journal of Biological Chemistry.

[37]  C. Wahlestedt,et al.  Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides , 1986, Regulatory Peptides.

[38]  H. Sitte,et al.  Oligomerization of the Human Serotonin Transporter and of the Rat GABA Transporter 1 Visualized by Fluorescence Resonance Energy Transfer Microscopy in Living Cells* , 2001, The Journal of Biological Chemistry.

[39]  A. Beck‐Sickinger,et al.  The first reporter gene assay on living cells , 2002, Molecular biotechnology.

[40]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[41]  P. Selvin.  Fluorescence resonance energy transfer. , 1995, Methods in enzymology.

[42]  C. Martínez-A,et al.  The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Michel Bouvier,et al.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.

[44]  A. Beck‐Sickinger.  Structural characterization and binding sites of G-protein-coupled receptors , 1996 .

[45]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[46]  U. Kumar,et al.  Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.

[47]  P. Seeman,et al.  Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.

[48]  Paul D. Scott,et al.  Dimerization of G-protein-coupled receptors. , 2001 .

[49]  K. Koller,et al.  Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors , 1997, Regulatory Peptides.

[50]  James F. Flood,et al.  Modulation of memory processing by neuropeptide Y , 1987, Brain Research.

[51]  E. Brown,et al.  The Extracellular Calcium-sensing Receptor Dimerizes through Multiple Types of Intermolecular Interactions* , 2001, The Journal of Biological Chemistry.

[52]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[53]  L. Devi,et al.  Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. , 2001, Trends in pharmacological sciences.